Cardiology Today


The following articles appeared in the print edition of CARDIOLOGY TODAY.

Table of Contents
5 Questions

Margo B. Minissian, PhD, ANCP, discusses evolution of women’s CV health

Cardiac Safety Research Consortium Update

Cardiogenic shock: Defining the clinical and regulatory landscape

Marc Samsky, MD

Cover Story

New trial data show mixed findings for omega-3s

FDA News

Second-generation antidote for two direct oral anticoagulants approved

In the Journals

Modifiable risk factors prevalent in young patients with MI

AHA: Nearly half of all US adults have CVD

Report: Cost, quality, development issues among barriers in fighting CVD

In HFrEF, women face poorer quality of life, receive less treatment vs. men

Cardiac dysfunction prevalent in patients with HIV

Aspirin increases risk for major bleeding, decreases CV risk in those without CVD

Intensive BP control reduces risk for mild cognitive impairment

Apixaban plus aspirin may be beneficial after MitraClip implantation

Anti-inflammatory psoriasis agents could reduce coronary artery plaque

Statin therapy reduces CV risks across age groups, including elderly

Updated AF guidelines recommend newer oral anticoagulants for stroke prevention

Canakinumab not cost-effective to prevent recurrent CV events after MI

Hormone therapy increases risk for stroke, VTE in transgender women

Meeting News

Adding cilostazol to antiplatelet therapy reduces recurrent ischemic stroke risk

ISET town hall calls attention to paclitaxel-coated devices

ANNEXA-4: Andexanet alfa successfully reverses factor Xa inhibitor effects

LIBERTY 360°: Endovascular interventions improve outcomes across all Rutherford classes

Pharmacology Consult

Ultrasound-assisted, catheter-directed therapy for pulmonary embolism: Breaking down the evidence

Dustin D. Spencer, PharmD, MBA, BCPS, BCCP

Trial Scorecards